Rosaria Falcon

  • Citations Per Year
Learn More
MELANOMA BRIDGE 2015 KEYNOTE SPEAKER PRESENTATIONS Molecular and immuno-advances K1 Immunologic and metabolic consequences of PI3K/AKT/mTOR activation in melanoma Vashisht G. Y. Nanda, Weiyi Peng, Patrick Hwu, Michael A. Davies K2 Non-mutational adaptive changes in melanoma cells exposed to BRAF and MEK inhibitors help the establishment of drug resistance(More)
request to discuss any matters disclosed in the Form 10–K.’’ The NRC staff is denying FMRI’s license amendment request because the proposed change does not provide assurance that the NRC will obtain sufficient information about FMRI’s future financial ability to meet its decommissioning obligations under the approved DP, as more fully set forth in the(More)
  • 1